Funded Tech Companies
Claris Bio
Wondering who invested in Claris Bio? Adage Capital Management, Catalio Capital Management and Aisling Capital joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Claris Bio
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
299 Pavonia Avenue 3-8
Jersey City, NJ 07302
USA
Jersey City, NJ 07302
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Company Background Information
Overview
Claris is pioneering solutions for patient populations struggling with sight-threatening corneal diseases. Claris Biotherapeutics, licensing intellectual property from Massachusetts Eye and Ear Infirmary (MEEI) and accessing drug substance in an agreement with partner Kringle Pharma.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
7/28/2026
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
Clarke Atwell
Chief Medical Officer
Susan Orr
VP - Bus. Development
Henry Rath
Company Investors
- Adage Capital Management
- Catalio Capital Management (Matthew Hobson)
- Aisling Capital
- Mass General Brigham Ventures
- Sofinnova Partners (Maha Radhakrishnan)
- Samsara BioCapital (Mike Dybbs)
- Novo Holdings
- Janus Henderson Investors
- RA Capital
Browse more funded tech companies:
ClariPhy Communications | ClarisHealth
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs